4
Changes in Ownership
Viking Therapeutics, Inc. Filed Acc 0001209191-23-024227
Chief Financial Officer sold 97,839 shares at an average $18.00 ($1,761,310)
- Chief Financial Officer acquired 97,839 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ZANTE GREG · Chief Financial Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-11 | Exercise or conversion : show line 1 in the form | +3,242 | $7.77 | $25,190 | 152,521 | D |
| 2023-04-11 | Exercise or conversion : show line 2 in the form | +8,500 | $4.68 | $39,780 | 161,021 | D |
| 2023-04-11 | Exercise or conversion : show line 3 in the form | +30,000 | $4.88 | $146,400 | 191,021 | D |
| 2023-04-11 | Exercise or conversion : show line 4 in the form | +14,553 | $5.80 | $84,407 | 205,574 | D |
| 2023-04-11 | Sale : show line 5 in the form | −56,295 | $18.00 | $1,013,518 | 149,279 | D |
| 2023-04-12 | Exercise or conversion : show line 6 in the form | +37,447 | $5.80 | $217,193 | 186,726 | D |
| 2023-04-12 | Exercise or conversion : show line 7 in the form | +4,097 | $7.77 | $31,834 | 190,823 | D |
| 2023-04-12 | Sale : show line 8 in the form | −41,544 | $18.00 | $747,792 | 149,279 | D |
| Open-market sales · 97,839 sh · avg $18.00 · $1,761,310 | ||||||
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-11 | Exercise or conversion : show line 9 in the form Stock Option (right to buy) | −3,242 | 16,847 | D |
| 2023-04-11 | Exercise or conversion : show line 10 in the form Stock Option (right to buy | −8,500 | 8,500 | D |
| 2023-04-11 | Exercise or conversion : show line 11 in the form Stock Option (right to buy | −30,000 | 90,000 | D |
| 2023-04-11 | Exercise or conversion : show line 12 in the form Stock Option (right to buy | −14,553 | 63,447 | D |
| 2023-04-12 | Exercise or conversion : show line 13 in the form Stock Option (right to buy | −37,447 | 26,000 | D |
| 2023-04-12 | Exercise or conversion : show line 14 in the form Stock Option (right to buy) | −4,097 | 12,750 | D |
Loading xslF345X04/doc4.xml…